Details for 2019151897

Up to date per 02.04.2026

Actions

Title / Product Name

ZUSAMMENSETZUNGEN AUS DOLUTEGRAVIR UND LAMIVUDIN ZUR BEHANDLUNG VON DURCH HIV VERURSACHTEN INFEKTIONEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019151897

EP Publication Number

3494972

E-Number

1639900

Language

PCT Number

Publication Date

12.06.2019 A

13.12.2023 B1

Registration Date

13.12.2023

AT Publication Date

15.01.2024

Application Date

24.01.2011

Registration Number

Priorities

27.01.2010

29858910 P

IPC

A61K 31/513 20060101AFI20230622BHEP

Maximum Duration of Protection

24.01.2031

Owner

VIIV Healthcare Company251 Little Falls Drive Wilmington, DE 19808US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

UNDERWOOD, Mark Richardc/o GlaxoSmithKline, Global Patents Dept Five Moore Drive Research Triangle Park NC North Carolina 27709US

Information about Fees